Effect of subcutaneous recombinant human erythropoetin in cancer patients receiving radiotherapy: Final report of a randomized, open-labelled, phase II trial

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 1996-2002

  Sweeney, P J ^a   Nicolae, D ^a   Ignacio, L ^a   Chen, L ^a   Roach III, M ^b   Wara, W ^b   Marcus, K C ^c   Vijayakumar, S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anaemia in cancer; Erythropoietin; Radiotherapy

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; BLOOD CELL COUNT; BREAST CARCINOMA; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IRON THERAPY; LUNG CARCINOMA; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; UTERINE CERVIX CARCINOMA;

ANEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE;

EID: 0031749540     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.331     Document Type: Article

References (65)

1. Abels RI (1992a) Recombinant human erythropoetin in the treatment of cancer. Acta Haematologica 87 (suppl. 1):4-11
2. Abels RI (1992b) Use of recombinant human erythropoetin in the treatment of anemia in patients who have cancer. Sem Oncol 19 (suppl. 3): 29-35
3. Abels RI (1993) Erythropoetin for anemia in cancer patients. Eur J Cancer 29A (suppl. 2): 2-8
4. Arnoux R, Corman J, Peloquin A, Smeesters C and St-Louis G (1988) Adverse effect of blood transfusions on patient survival after resection of rectal cancer. Can J Surg 31: 121-126
5. Blitzer PH, Wang CC and Suit HD (1984) Blood pressure and hemoglobin concentration: Multivariate analysis of local control after irradiation for head and neck cancer. Int J Radiat Oncol Biol Phys 10 (suppl. 2): 98
6. Blumberg N and Heal JM (1990) Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection. Yale J Biol Med 63: 429-433
7. Blumberg N, Agarwal MM and Chuang C (1988) A possible association between survival time and transfusion in cervical cancer. Yale J Biol Med 61: 493-500
8. Bove JR (1987) Transfusion-associated hepatitis and AIDS. N Engl J Med 317: 292-295
9. Bush RS (1986) The significance of anemia in clinical radiotherapy. Int J Radiat Oncol Biol Phys 12: 2047-2050
10. Bush RS, Jenkin RDT, Allt WEC, Beale FA, Bean H, Dembo AJ and Pringle JF (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37 (suppl. III): 302-306
11. Bunn HF (1991) Anemia. In Harrison's Principles of Internal Medicine, Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS and Boot RK (eds). McGraw-Hill: New York, pp. 344-348
12. Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, Salmon SE, Silver RT, Storniolo AM, Wampler GL, Dooley CM, Larholt KM and Abels RI (1993) Recombinant human erythropoetin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85: 801-806
13. Casper ES, Gaynor JJ, Hadju SI, Magill GB, Tan C, Friedrich C and Brennan MF (1991) A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high grade extremity soft tissue sarcoma and an analysis of prognostic factors. Cancer 68: 1221-1229
14. Corman J, Arnoux R, Peloquin A, St-Louis G and Smeesters C (1988) Perioperative blood transfusions and colorectal cancer outcome. Transplant Proc 20: 1128-1129
15. deCampos E, Radford J, Steward W, Milroy R, Dougal M, Swindell R, Testa N and Thatcher N (1995) Clinical and in-vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer. J Clin Oncol 13: 1623-1631
16. Dische S (1991) Radiotherapy and anemia - the clinical experience. Radiother Oncol 20: 35-40
17. Dische S, Anderson PJ, Sealy R and Watson ER (1983) Carcinoma of the cervix - anemia, radiotherapy and hyperbaric oxygen. Br J Radiol 56: 251-255
18. Ds̊hrsen U and Hossfeld DK (1994) Hematopoietic growth factors and the treatment of tumor-associated anemias. Ann Hematol 69: 213-221
19. Dubray B, Mosseri V, Brunin F, Jaulerry C, Poncet P, Rodriguez J, Brugšre J, Point D, Giraud P and Cosset J (1996) Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 201: 553-558
20. Dusenbery KE, McGuire WA, Holt PJ, Carson LF, Fowler JM, Twiggs LB and Potish RA (1994) Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 29: 1079-1084
21. Egrie JC, Cotes PM, Lane J, Das Gaines RE and Tam RC (1987) Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods 99: 235-241
22. Esbach JW, Abduljadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR, Korbett S, Krantz SB, Lundin AP, Nissenson AR, Ogden DA, Paganini EP, Rader B, Rutsky EA, Stivelman J, Stone WJ, Teschan P, Van Stone JC, Van Wyck DB, Zuckerman K and Adamson JW (1989) Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Int Med 111: 992-1000
23. Evans J and Bergso P (1965) The influence of anemia on the results of radiotherapy in carcinoma of the cervix. Radiology 48: 709-717
24. Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC and Rudnick S (1990) Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322: 1488-1493
25. Girinski T, Pejovic-Lenfant MH, Bourhis J, Campana F, Cosset JM, Petit C, Malaise EP, Haie C, Gerbaulet A and Chassagne D (1989) Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a prospective study of 386 patients. Int J Radiat Oncol Biol Phys 16: 37-42
26. Goldberg MA, Dunning SP and Bunn HF (1988) Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein. Science 242: 1412
27. Gray LH, Conger AD, Ebert M, Hornsey S and Scott OCA (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 638-648
28. Heal JM, Chuang C and Blumberg N (1988) Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg 156: 374-379
29. Hierlihy P, Jenkin RDT and Stryker JA (1969) Anemia as a prognostic factor in cancer of the cervix: a preliminary report. Can Med Ass J 100: 1100-1102
30. Hirst DG (1986) Anemia: Problem or opportunity in radiotherapy? Int J Radiat Oncol Biol Phys 12: 2009-2017
31. Jacobson LO, Goldwasser E, Fried W and Plzak L (1957) Role of the kidney in erythropoiesis (letter). Nature 179: 633-635
32. Kettelhack C, Schöter D, Matthias D and Schlag PM (1994) Serum erythropoietin levels in patients with solid tumors. Eur J Cancer 30A: 1289-1291
33. Kushner JB (1992) Hypochromic anemias. In Cecil Textbook of Medicine, Wyngaarden JB, Smith LH and Bennett JC (eds). WB Saunders: Philadelphia
34. Lavey RS and Dempsey WH (1993) Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 27: 1147-1152
35. Lee G (1983) The anemia of chronic disease. Semin Hematol 20: 61-80
36. Leitgeh C, Pecherstorfer M, Fritz E and Ludwig H (1994) Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 73: 2535-2542
37. Levine EA and Vijayakumar S (1993) Blood transfusion in patients receiving radical radiotherapy: a reappraisal. Onkologie 16: 79-87
38. Little AG, Wu H-S, Ferguson MK, Ho C-H, Bowers VD, Segalin A and Staszek VM (1990) Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small cell lung cancer. Am J Surg 160: 630-633
39. Longo DL (1993) Anemia in patients with cancer. Clin Oncol Alert (suppl.)
40. Ludwig H, Leitgeb C, Fritz E, Krainer M, Kšhrer I, Kornek G, Sagaster P and Weissman A (1993) Erythropoietin treatment of chronic anemia of cancer. Eur J Cancer 29A (suppl. 2): 8-12
41. Ludwig H, Fritz E, Leitgeb C, Pecherstorfer M, Samonigg H and Schuster J (1994) Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood 84: 1056-1063
42. McClinton S, Moffat LEF, Scott S, Urbaniak SJ and Kerridge DF (1990) Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 77: 140-142
43. Mendenhall WM, Thar TL, Bova FJ, Marcus RB, Morgan LS and Million RR (1984) Prognostic and treatment factors affecting pelvic control of Stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 53: 2649-2654
44. Miller CB, Jones RJ, Plantadosi S, Abeloff MD and Spivak JL (1990) Decreased erythropoietin response in patients with anemia of cancer. N Engl J Med 322: 1689-1692
45. Miller CB, Platanias LC, Mills SR, Zahurak ML, Ratain MJ, Ettinger DS and Jones RJ (1992) Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst 84: 98-103
46. Moores DWO, Piantadosi S and McKneally MF (1989) Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg 47: 345-351
47. Overgard J, Hansen HS, Anderson AP, Hjelm-Hansen M, Jørgensen K, Sandberg E, Berthelsen A, Hammer R and Pedersen M (1989) Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 Study. Int J Radiat Oncol Biol Phys 16: 1065-1068
48. Palcic B and Skarsgard LD (1984) Reduced oxygen enhancement ratio at low doses of ionizing radiation. Radiat Res 100: 328-339
49. Platanias LC, Miller CB, Mick RM, Hart RD, Ozer H, McEvilly JM, Jones RJ and Ratain MJ (1991) Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients. J Clin Oncol 9: 2021-2026
50. Poskitt TR (1987) Radiation therapy and the role of red blood cell transfusion. Cancer Invest 5: 231-236
51. Rader JS, Haraf DJ, Halpern HJ, Rotmensch J, Spelbring DR, Sutton H, Javaheri G and Weichselbaum RW (1990) Radiation therapy in the treatment of cervical cancer: The University of Chicago/Michael Reese Hospital experience. J Surg Oncol 44: 157-165
52. Rosenberg SA, Seipp CA, White DE and Wesley R (1985) Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol 3: 693-709
53. Samuels AJ and Bierman HR (1956) Anemia in patients with neoplastic disease. Calif Med 84: 180-184
54. Spivak JL (1989) Erythropoietin: a brief review. Nephron 52: 289-294
55. Spivak J (1992) The application of recombinant erythropoietin in anemic patients with cancer. Sem Oncol 19 (suppl. 8): 25-28
56. Spivak JL (1994) Editorial: Recombinant human erythropoietin and the anemia of cancer. Blood 84: 997-1004
57. Tartter PI, Burrows L, Papatestas AE, Lesnick G and Aufses AH Jr (1985) Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 97: 225-229
58. Van Wyck DB (1989) Iron management during recombinant human ery thropoietin therapy. Am J Kidney Dis 14 (suppl. 1): 9-13
59. Vigario G, Kurohara SS and George FW (1973) Association of hemoglobin levels before and during radiotherapy with prognosis in uterine cervix cancer. Radiology 106: 649-652
60. Vijayakumar S, Roach M, Wara W, Chan SK, Ewing C, Rubin S, Sutton H, Halpern H, Awan A, Houghton A, Quiet C and Weichselbaum R (1993) Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, phase II trial. Int J Radiat Oncol Biol Phys 26: 721-729
61. Vijayakumar S, Nautiyal J, Roach M, Marcus KC, Vaida F and Wara W (1998) Beneficial effects of high doses of human recombinant erythropoietin on platelets: An unexpected finding of a randomized, open labeled clinical study in cancer patients. Radiat Oncol Invest
62. Wang FF, Kung CK and Goldwasser E (1985) Some chemical properties of human erythropoietin. Endocrinology 116: 2286-2292
63. Wobbes T, Joosen KHG, Kuypers HHC, Beerthuuizen GIJM and Theeuwes GM (1989) The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma. Dis Colon Rectum 32: 743-748
64. Yang FY, Vaida F, Ignacio L, Houghton A, Nautiyal J, Halpern H, Sutton H and Vijayakumar S (1995) Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy. Int J Radiat Oncol Biol Phys 33: 607-617
65. Zanjani ED and Ascensao JL (1989) Erythropoietin. Transfusion 29: 46-57